Search

Word Search

Information System News

10 Jev Projects on GitHub You Should Check Out

Rick W 0 9
Agents make dozens of small decisions before producing useful output: which source to trust, which tool to call, what context to keep and when to stop. Jev brings those hidden choices into the open by turning them into typed decisions with probabilities, instead of relying on free-form text alone.  That makes it useful across browser […] The post 10 Jev Projects on GitHub You Should...

Stop Overpaying for AI Power You Don't Need - with Melissa Ramey of Salesforce

Rick W 0 8
An AI agent can function as designed yet produce results an organization cannot verify or safely use. In this episode, Melissa Ramey, Director, AI Transformation – Data Insights and User Experience at Salesforce, joins Emerj's Yolandi de Weerdt to examine who owns agent behavior after deployment and why correcting individual outputs does not fix the underlying workflow. She explains how...

JEV vs LLM as a Judge: The AI Evaluation Comparison

Rick W 0 11
Many teams now use LLM-as-a-Judge to check AI answers, especially when exact-match tests fail for long or open-ended responses. But every judgement adds cost, delay, and possible bias, making this hard to scale.  Jev, a small decision model from TypeSafe AI, takes a leaner route: it returns a short choice with confidence instead of full […] The post JEV vs LLM as a Judge: The AI...

E568 Inside the AI-Native Law Firm Transforming Legal Services with Vector Legal's Keenan Venuti

Rick W 0 10
Today's guest is Keenan Venuti, CTO & Co-Founder at Vector Legal. Founded in 2026, Vector Legal is an AI-native law firm based in San Francisco serving startups, growth-stage companies, venture capital firms and private equity investors. Combining experienced attorneys with proprietary AI technology, the organization supports clients from company formation through fundraising, commercial...

Turning Biological Complexity into R&D Advantage with Virtual Cells - with Giorgio Gaglia of Sanofi & Daniel Veres of Turbine

Rick W 0 9
Drug discovery teams are running short of new ideas to test, and AI models that simulate how cells respond to drugs only pay off once leaders know when those predictions can be trusted with experiments, timelines, and budget.   In this episode, Daniel Veres, Co-Founder and Chief Scientific Officer at Turbine, and Giorgio Gaglia, Head of Systems and Disease Biology at Sanofi, examine...

Building an Enterprise AI Customer Support Platform with Claude Fable 5.1 and Claude Code

Rick W 0 24
Most AI coding demos stop at task managers, weather apps, or simple chatbots. For this project, we take on something more demanding: building an enterprise customer-support platform that can investigate complaints, retrieve relevant policies, recommend resolutions, and keep risky actions behind human approval. This gives us a practical way to test Claude Fable 5.1 as […] The post...

Bringing predictive analytics to the agentic AI era 

Rick W 0 18
In 2026, the question for enterprise AI is no longer whether predictive models can outperform statistical forecasts—that argument is settled. The big question now is how to enable predictive systems to act on their own conclusions without drifting from business intent. The frontier has moved from prediction to autonomous decision making, and the gap between…